Spruce Biosciences Inc logo

Spruce Biosciences Inc Share Price Today (NASDAQ: SPRB)

Spruce Biosciences Inc share price is $0.07 & ₹6.06 as on 27 Apr 2025 IST

$0.07

▲

-0.01

(-12.5%)

Market is closed - opens 7 PM, 23 Jun 2025

Bell Icon

The stock has been delisted from the stock exchange on 28 Apr 2025

View live Spruce Biosciences Inc share price in Dollar and Rupees. Guide to invest in Spruce Biosciences Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Spruce Biosciences Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Spruce Biosciences Inc (SPRB) Key Statistics

in dollars & INR

Previous Close
$0.08
Open
$0.081
Market Capitalization
$3.3M
Today's Volume
$2.9M
Revenue TTM
$4.9M
EBITDA
$-56.1M
Earnings Per Share (EPS)
$-1.29
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-100.7%

How to invest in Spruce Biosciences Inc Stock (SPRB) from India?

It is very easy for Indian residents to invest directly in Spruce Biosciences Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Spruce Biosciences Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Spruce Biosciences Inc or SPRB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Spruce Biosciences Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Spruce Biosciences Inc shares which would translate to 12.367 fractional shares of Spruce Biosciences Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Spruce Biosciences Inc, in just a few clicks!

Global Institutional Holdings in Spruce Biosciences Inc

  • RiverVest Venture Management LLC

    6.96%

  • The Carlyle Group Inc

    6.86%

  • Rock Springs Capital Management LP

    6.18%

  • Ikarian Capital, LLC

    2.37%

  • Vanguard Group Inc

    2.00%

  • Sands Capital Ventures, LLC

    1.70%

Analyst Recommendation on Spruce Biosciences Inc

Rating
Trend

Buy

    53%Buy

    46%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Spruce Biosciences Inc(by analysts ranked 0 to 5 stars)

About Spruce Biosciences Inc

Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction in adult patients with classic CAH that is Phase 2b clinical trial. It is also developing tildacerfont for the treatment of pediatric classic congenital adrenal hyperplasia in children that is in Phase 2 clinical trial; and for females with polycystic ovary syndrome, which is in Phase 2 clinical trial. Spruce Biosciences, Inc. has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses; and collaboration and license agreement with Kaken Pharmaceutical Co. Ltd. to develop, manufacture, and commercialize tildacerfont for the treatment of CAH in Japan. The company was incorporated in 2014 and is headquartered in South San Francisco, California.
Organization
Spruce Biosciences Inc
Employees
21
CEO
Dr. Javier Szwarcberg M.D., M.P.H.
Industry
Commercial Services

Management People of Spruce Biosciences Inc

NameTitle
Mr. Michael G. Grey
Executive Chairman
Dr. Javier Szwarcberg M.D., M.P.H.
CEO & Director
Dr. Kirk Ways M.D., Ph.D.
Chief Medical Officer & Director
Ms. P. J. Ramtin
Senior Vice President of Business Operations
Ms. Heidi Petersen M.P.H.
Senior Vice President of Regulatory & Quality

Important FAQs about investing in SPRB Stock from India :

Can Indians buy Spruce Biosciences Inc shares?

Yes, Indians can invest in the Spruce Biosciences Inc (SPRB) from India.

With INDmoney, you can buy Spruce Biosciences Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Spruce Biosciences Inc at zero transaction cost.

How can I buy Spruce Biosciences Inc shares from India?

It is very easy to buy Spruce Biosciences Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Spruce Biosciences Inc (SPRB) be purchased?

Yes, you can buy fractional shares of Spruce Biosciences Inc with INDmoney app.

What are the documents required to start investing in Spruce Biosciences Inc stocks?

To start investing in Spruce Biosciences Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Spruce Biosciences Inc?

Today's market capitalisation of Spruce Biosciences Inc SPRB is 3.3M

Who is the Chief Executive Officer (CEO) of Spruce Biosciences Inc ?

Dr. Javier Szwarcberg M.D., M.P.H. is the current Chief Executive Officer (CEO) of Spruce Biosciences Inc.